Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Elife|October 23, 2020
Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activationGeorg Kuenze, Carlos G Vanoye, Reshma R Desai, et al.
Pain Management|April 23, 2026
Patient perspectives on non‑traumatic painful upper‑extremity conditions, co-occurring risky substance use, and an integrated web-based mind-body intervention addressing both conditionsJulie R Brewer, Pearl Lee, Nadine Levey, et al.
Neurotoxicology|January 1, 1995
Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposureE Cernichiari, R Brewer, G J Myers, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2025
Integrative analysis of KCNQ1 variants reveals molecular mechanisms of type 1 long QT syndrome pathogenesisKathryn R Brewer, Carlos G Vanoye, Hui Huang, et al.
Shock (Augusta, Ga.)|November 26, 2019
Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future StudiesMabel N Abraham, Alexander P Kelly, Ariel B Brandwein, et al.
The International Journal of Biochemistry & Cell Biology|November 22, 2021
SSX2 promotes the formation of a novel type of intranuclear lamin bodiesS Traynor, N D Jakobsen, M F Ebbesen, et al.
Nano Letters|June 2, 2011
Defect engineering in cubic cerium oxide nanostructures for catalytic oxidationNeil J Lawrence, Joseph R Brewer, Lu Wang, et al.
British Journal of Pharmacology|February 26, 2016
Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2 O2 in resistance arteries from patients with cardiovascular diseaseThomas M Leurgans, Maria Bloksgaard, Jonathan R Brewer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapyLianne Hu, Chaohong Fan, Peter Bross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2020
An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate CancerMichael Brave, Chana Weinstock, Jamie R Brewer, et al.
Pageof 20